Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism.
The spectrum of classic symptoms of hyperthyroidism suggests that in addition to the effects of increased thyroid hormone, affecting various organ systems, there is also a hyperadrenergic state. Despite this clinical impression, direct measures of serum levels of catecholamines and their urinary metabolites demonstrate values that are equal to or less than normal. In contrast, the hypothyroid patient who clinically manifests signs of decreased adrenergic stimulation can be expected to have increased levels of epinephrine, norepinephrine, and its metabolites. This review discusses possible mechanisms to explain this seeming paradox. Treatment of hyperthyroidism includes the rapid reversal of many of the adrenergic symptoms with use of beta-blocking drugs. Return to a clinically and chemically euthyroid state, however, requires antithyroid therapy accomplished over a longer period of time. A knowledge of the interaction of the cardiovascular and extracardiovascular manifestations of hyperthyroidism and the role of the adrenergic nervous system is important in the rational management of these patients.
Department of Medicine, University of Pittsburgh School of Medicine, Pennsylvania 15213.
G S
GS
Levey
I
I
Klein
D002395:Catecholamines / Q000493:pharmacokinetics / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006980:Hyperthyroidism / Q000378:metabolism / Q000503:physiopathology*; D013565:Sympatholytics / Q000627:therapeutic use; D013963:Thyroid Hormones / Q000494:pharmacology*
D002395:Catecholamines; D013565:Sympatholytics; D013963:Thyroid Hormones